ASA Monitor May 2022, Vol. 86, 12. A 25-year-old man presents for laparoscopic cholecystectomy. He suffers from chronic low back pain and is using oxycodone, diazepam, and cannabis for pain management. According to a recent study, which of the following six-month outcomes is MOST likely in this patient compared with a similar patient who does not […]
Read MoreAuthor: Thomas R. Miller, PhD, MBA ASA Monitor May 2022, Vol. 86, 1–11. I wrote this column in February, that exciting time of the year when most publicly traded companies submit Form 10-K to the U.S. Securities and Exchange Commission. The 10-K is a comprehensive report filed each year to inform potential investors about a firm’s […]
Read MoreASA Monitor May 2022, Vol. 86, 34–35. In December, USA Today reported on the American Medical Association’s and American Hospital Association’s lawsuit against the U.S. Departments of Health and Human Services, Labor, and Treasury over flawed regulations in implementing the No Surprises Act, noting that ASA is in agreement. “The rules are a powerful mechanism for […]
Read MoreAuthors: Kunal Karamchandani, M.D., FCCP et al ASA Monitor February 2020, Vol. 84, 30–32. Opioids impact intensivists in multiple ways. While opioids form the cornerstone of managing pain and sedation in the intensive care unit (ICU), the significant increases in opioid use-related admissions in the wake of the opioid epidemic are concerning. Pain is ubiquitous in the […]
Read MoreAuthors: Timothy D. Quinn, M.D. et al ASA Monitor May 2019, Vol. 83, 14–16 Anesthesiologist Intensivists and Evaluating High-risk Surgical Patients Perioperative management of high-risk surgical patients poses many challenges. Patients may be deemed high risk based on poor baseline functional status, severe or uncontrolled co-morbidities, poor scores on risk and frailty calculators, invasiveness of the […]
Read More